Terms: = Lung cancer AND TPM4, P67936, 7171, ENSG00000167460
14 results:
1. Plasma Exosomal CXCL7 is a Potential Biomarker for lung Adenocarcinoma.
Fang W; You J; Xu Q; Jiang Y; Hu H; Chen F; Chen L
Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250818
[TBL] [Abstract] [Full Text] [Related]
2. Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition.
Tian J; Wang V; Wang N; Khadang B; Boudreault J; Bakdounes K; Ali S; Lebrun JJ
Breast Cancer Res; 2021 Feb; 23(1):23. PubMed ID: 33588911
[TBL] [Abstract] [Full Text] [Related]
3. Lorlatinib for the treatment of inflammatory myofibroblastic tumour with tpm4-ALK fusion following failure of entrectinib.
Wong HH; Bentley H; Bulusu VR; Anyaegbu G; Watkins J; Horan G; Hatcher H
Anticancer Drugs; 2020 Nov; 31(10):1106-1110. PubMed ID: 32868646
[TBL] [Abstract] [Full Text] [Related]
4. The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements.
Suurmeijer AJ; Dickson BC; Swanson D; Zhang L; Sung YS; Huang HY; Fletcher CD; Antonescu CR
Genes Chromosomes Cancer; 2019 Nov; 58(11):739-746. PubMed ID: 31112350
[TBL] [Abstract] [Full Text] [Related]
5. Identification of SUV39H2 as a potential oncogene in lung adenocarcinoma.
Zheng Y; Li B; Wang J; Xiong Y; Wang K; Qi Y; Sun H; Wu L; Yang L
Clin Epigenetics; 2018 Oct; 10(1):129. PubMed ID: 30348215
[TBL] [Abstract] [Full Text] [Related]
6. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
Parker BM; Parker JV; Lymperopoulos A; Konda V
J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
[TBL] [Abstract] [Full Text] [Related]
7. Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery.
Campa MJ; Moody MA; Zhang R; Liao HX; Gottlin EB; Patz EF
Cancer Immunol Immunother; 2016 Feb; 65(2):171-80. PubMed ID: 26739486
[TBL] [Abstract] [Full Text] [Related]
8. ALKoma: a cancer subtype with a shared target.
Mano H
Cancer Discov; 2012 Jun; 2(6):495-502. PubMed ID: 22614325
[TBL] [Abstract] [Full Text] [Related]
9. Peroxiredoxins and tropomyosins as plasma biomarkers for lung cancer and asbestos exposure.
Rostila A; Puustinen A; Toljamo T; Vuopala K; Lindström I; Nyman TA; Oksa P; Vehmas T; Anttila SL
Lung Cancer; 2012 Aug; 77(2):450-9. PubMed ID: 22537621
[TBL] [Abstract] [Full Text] [Related]
10. Exosomal microRNA: a diagnostic marker for lung cancer.
Rabinowits G; Gerçel-Taylor C; Day JM; Taylor DD; Kloecker GH
Clin Lung Cancer; 2009 Jan; 10(1):42-6. PubMed ID: 19289371
[TBL] [Abstract] [Full Text] [Related]
11. Differences in gene expression levels between early and later stages of human lung development are opposite to those between normal lung tissue and non-small lung cell carcinoma.
Kopantzev EP; Monastyrskaya GS; Vinogradova TV; Zinovyeva MV; Kostina MB; Filyukova OB; Tonevitsky AG; Sukhikh GT; Sverdlov ED
Lung Cancer; 2008 Oct; 62(1):23-34. PubMed ID: 18394749
[TBL] [Abstract] [Full Text] [Related]
12. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry.
Li DQ; Wang L; Fei F; Hou YF; Luo JM; ; Zeng R; Wu J; Lu JS; Di GH; Ou ZL; Xia QC; Shen ZZ; Shao ZM
Proteomics; 2006 Jun; 6(11):3352-68. PubMed ID: 16637015
[TBL] [Abstract] [Full Text] [Related]
13. Solitary pulmonary nodules: a comparative study evaluated with contrast-enhanced dynamic MR imaging and CT.
Kim JH; Kim HJ; Lee KH; Kim KH; Lee HL
J Comput Assist Tomogr; 2004; 28(6):766-75. PubMed ID: 15538149
[TBL] [Abstract] [Full Text] [Related]
14. Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: a retrospective European multi-center analysis.
Koscielniak E; Rodary C; Flamant F; Carli M; Treuner J; Pinkerton CR; Grotto P
Med Pediatr Oncol; 1992; 20(3):209-14. PubMed ID: 1574030
[TBL] [Abstract] [Full Text] [Related]
